Auto-Injectors Market
Auto-Injectors: A Better, Safe, And User-Friendly Drug Delivery Technology! Explore More with FMI
Auto-Injectors Market by Product, Indication, Distribution Channel & Region - Forecast 2022 – 2032
Auto-Injectors Market Outlook (2022-2032)
[276 Pages Report] The global auto-injectors market is expected to enjoy a valuation of US$ 3.5 Bn in 2022, and is further expected to expand at an impressive CAGR of 21.4% between 2022 and 2032, to reach a valuation of ~US$ 23.9 Bn 2032. Rising prevalence of various diseases including diabetes, anaphylaxis, and multiple sclerosis and increase in self administration of drugs are some of the key factors driving demand for auto-injectors in the market.
Based on the products, prefilled auto-injectors segment dominated the global autoinjector market with a share of about 91.7% in 2021 and the trend is likely to continue even during the forecast period.
|
Attribute |
Key Statistics |
|
Auto-Injectors Market Base Value (2021) |
US$ 3.1 Bn |
|
Estimated Market Size (2022) |
US$ 3.5 Bn |
|
Projected Market Size (2032) |
US$ 23.9 Bn |
|
Value-based CAGR (2022-2032) |
21.4% |
|
Market Share of Top 5 Countries |
84.4% |
Auto-injector devices are medical devices that are used to deliver a dose of a particular drug. They are very helpful in lowering the dependency on medical professionals to some extent. These specialized medical devices can be used to reduce the injuries related to the needle stick and help in reducing the phobia due to the needle that is quite common among patients. They are being preferred over traditional drug delivery systems due to their various advantages including user-friendliness, better accuracy, and less pain
Autoinjectors act as an aid in ensuring painless drug delivery of the complete dosage. Due to the convenience that these autoinjectors provide to the patients, the auto-injectors market is anticipated to grow at a marvellous pace during the assessment period.
With global burden of chronic diseases continuing to surge rapidly, people are opting for various novel treatments to manage and treat these diseases as well as to relieve symptoms. However, traditional drug delivery methods or systems are time consuming, cumbersome, inconvenient, and painful. As a result, people are looking for better and advanced drug delivery systems like autoinjectors.
Rapid surge in chronic diseases and growing trend of administering medical products like insulin at homes will continue to boost market growth during the assessment period.
Let us know your requirement to get
100% FREE customization
Sales Analysis of Auto-Injectors from 2014 to 2021 Vs Market Outlook for 2022 to 2032
The global sales of auto-injectors grew at a CAGR of around 14.4% during the historical period of 2014 and 2021, and totalled a valuation of US$ 3.1 Bn in 2021. However, with rapid shift towards advanced and user-friendly drug delivery systems, the overall demand for autoinjectors is slated to grow at 21.4% CAGR between 2022 and 2032.
Auto-injectors have been preferred over conventional devices because they provide benefits such as easy self-administration, improved patient compliance, dosage accuracy, reduce the risk of needlestick injuries, and are easy to use. They have become ideal self-injectable devices worldwide.
The innovative designs of the autoinjectors have helped in enhancing efficiency concerning drug delivery. They have become more suitable for patients who require self-injections on a daily or weekly basis. Increasing demand for self-administration devices for the management and treatment of various indications across the globe is expected to boost revenue growth in the auto-injector devices market.
Auto-injectors are quite convenient in providing various advantages to patients. These advantages include ease of use and fast and simple administration during emergency as well as non-emergency environments. Devices such as autoinjectors and pen injectors are rising to prominence because of their user-friendly nature.
Similarly, technological advancements are opening the way for autoinjector devices that assure minimum error rates for first-time patients while also ensuring exact dosage of the drug that the patient wishes to self-administer. This will have a beneficial impact on the growth of the auto-injectors market.
The rising prevalence of chronic illnesses across the globe will continue to act as a catalyst triggering the growth of auto-injectors market. Chronic diseases majorly lead to an increasing number of deaths and an increasing number of disabled patients, worldwide. According to the World Health Organization (WHO), most chronic diseases were projected to lead to 73% of all deaths and 60% of the global burden of diseases. For example, multiple sclerosis, which is a chronic autoimmune disorder, is progressively increasing in developed countries like the U.S. As per the findings from the National Multiple Sclerosis Society, it was reported that around 1 million people in the U.S. were living with multiple sclerosis in 2019. This is a plus point for the growth of the auto-injectors market.
What are the Key Trends Driving the Auto-Injectors Market?
“Rise in Chronic Diseases and Growing Popularity of Point-of-Care Devices to Bolster Market Growth”
The global auto-injectors market is set to witness high growth rate, owing to the initiatives by the governments in developing nations, growing demand for point-of-care devices, and rising awareness among people regarding the benefits of autoinjectors over traditional drug delivery systems.
Auto-injectors are an easy and simplified version of syringes and involve self-administration of drugs. Drug dosage from an auto-injector is more controlled and consistent than from manual syringes.
Also, the user-friendliness of the auto-injectors, growing number of product launches with improved functionality in the marketplace etc., increasing focus on safety and efficacy, and rising prevalence of diseases such as multiple sclerosis and anaphylaxis are expected to propel sales of auto-injectors in the market during the forthcoming years.
Similarly, growing need for treating and managing diseases like rheumatoid arthritis, diabetes, multiple sclerosis, and other disorders will continue to drive the global autoinjectors market. According to the International Diabetes Federation, roughly 463 million people worldwide suffered from diabetes in 2019, with the figure expected to climb to 700 million by 2045.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Growth of the Auto-Injectors Market?
The strict regulatory approvals, premium pricing, and recall of the products are some of the factors expected to restrain market growth during the forecast period.
The global auto-injectors market is enriched with patented technologies. Major players are pacing up with advanced product development in the global auto-injectors market. Limited competition and complex development processes lead to higher prices of auto-injectors. As a result, autoinjectors are available in the global market at a higher cost as compared to the alternative product's pre-filled syringes.
Moreover, pre-marketing approval is a lengthy and expensive process that influences the growth of the market.
Country-wise Insights
What Makes the U.S. a Large Market for Auto-Injectors?
“Increasing Incidence of Diabetes and Anaphylaxis Fuelling Market Growth in the U.S.”
The U.S. dominated North American auto-injectors market with a total market share of about 91.8% in 2021 and is expected to continue to experience the same growth throughout the forecast period. Rising prevalence of diseases like anaphylaxis and diabetes, availability of advanced drug delivery systems, increasing healthcare spending and strong presence of leading autoinjector manufacturers are some of the key factors driving growth in the U.S. auto-injectors market.
Over the years, there has been a sharp rise in diseases such as diabetes and anaphylaxis in the U.S. For instance, as per the Centers for Disease Control and Prevention (CDC) there are over 37.3 million people with diabetes in the United States. In order to manage their blood sugar levels, these people are highly dependent on insulin shots.
Similarly, as per the study conducted by the Asthma and Allergy Foundation of America (AAFA), anaphylaxis, a life-threatening allergic reaction, is common in the U.S. and occurs in about one in 50 Americans.
Thus, rise in cases of these medical conditions across the country along with prolonged usage of medications to manage them will continue to boost growth of the auto-injectors market during the forecast period.
Similarly, presence of favorable reimbursement policies and rising number of regulatory approvals will further expand the U.S. auto-injections market size during the forecast period.
What Makes Canada a Highly Lucrative Market for Auto-Injectors?
“Easy Accessibility to Autoinjectors Pushing Demand in Canadian Market”
Canada held approximately 8.2% share in the North American auto-injectors market in 2021 and is expected to witness a lucrative growth rate of 19.7% CAGR during the forecast period. Rising incidence of various chronic diseases, increasing health awareness among people, and growing popularity of auto-injectors for self-administration of various drugs are fuelling market growth in Canada.
EmeradeTM epinephrine auto-injectors are currently offered in pharmacies all over Canada, according to an October 2020 announcement from Bausch Health, Canada. Canadians now have a second epinephrine auto-injector option in the form of Emerade. Growing accessibility to auto-injector products will propel the overall market growth within the country.
What is the Demand Outlook for Auto-Injectors Market in Germany?
“Rising Usage of Auto-Injectors to Minimize the Risk of Needle Stick Injuries Fostering Market Growth in Germany”
As per FMI, the auto-injectors market in Germany is set to exhibit a CAGR of nearly 21.8% during the forecast period, owing to the rapid surge in life-threatening diseases, rising need for reducing needlestick injuries, and availability of advanced drug delivery products.
Germany is becoming increasingly popular when it comes to health and innovation. Increase in research and development and more focus on patented drug delivery technologies in the country will raise demand for the auto-injectors market.
Moreover, with established guidelines on patient safety and the rising prevalence of needle stick injuries, demand for autoinjectors is set to grow at a marvellous pace during the next ten years.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Which Product is High in Demand in the Global Auto-Injectors Market?
“Prefilled Auto-Injectors Will Remain Highly-Sought After Products in 2022 & Beyond”
As per FMI, prefilled auto-injectors segment held a massive share of about 91.7% in the global auto-injectors market in 2021 and it is expected to grow at a stupendous CAGR of 21.6% during the forecast period. This can be attributed to the rising end user preference for prefilled autoinjectors over fillable ones due to easy self-administration, reduced anxiety, and dosage accuracy.
Prefilled medications improve patient safety by reducing the possibility of accidental needle stick injuries and harmful product exposure that can arise while drawing drugs from vials.
Prefilled injection is convenient for those patients that require parenteral administration of drugs on a daily/weekly basis and long-term treatment. As such, they prefer self-administrated devices as they do not have to remain dependent on doctors for each dosage.
By Indication, Which Segment Will Generate the Highest Revenues in the Auto-Injectors Market?
“Demand for Auto-Injectors Will Remain High for Anaphylaxis”
Anaphylaxis segment held a revenue share of around 88.9% in 2021 and is expected to grow at the highest CAGR during the forecast period. Increased incidence of anaphylactic shock, preference of the patients to opt for self-administration injection devices, and companies focussing to improve functionality to advance their products technologically are driving growth of this segment.
People with potentially serious allergies like anaphylaxis are often prescribed to always carry adrenaline auto-injectors. These adrenaline auto-injectors can effectively stop an anaphylactic reaction from becoming life threatening. Thus, rise in cases of anaphylaxis will continue to push the demand for auto-injectors during the forecast period.
Which Distribution Channel Benefits the Most with the Sales of Auto-Injectors Globally?
“Online Pharmacies To Witness Highest Auto-Injector Sales”
Online pharmacies held the highest market share value of 38.6% in the auto-injectors market during 2021. Easy availability of the products with wide varieties has made it easy for consumers to buy products online with affordability, propelling sales of the overall auto-injectors market.
People today are more inclined towards purchasing medications and drug delivery devices from online pharmacies to reduce the overall expenses and save their time. Besides this, these online pharmacies offer various discounts and home delivery options to woo customers. All these factors will position the online pharmacies segment as a dominant distribution channel in the market.
Competitive Landscape
Key manufacturers of autoinjectors are using strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, and price reduction to increase their client base and gain a competitive edge in the market. For instance,
- In September 2021, Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd. launched its new Aidaptus auto-injector platform. The new device is a 2-step, spring-powered, single use auto-injector designed to accommodate both 1 mL and 2.25 mL prefilled glass syringes in the same base device.
- In April 2022, Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced the signing of a formal agreement under which Halozyme will acquire Antares.
- In June 2020, Mylan N.V. and Biocon Ltd. announced the U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA) for SemgleeTM (insulin glargine injection), in the vial and pre-filled pen forms, to control high blood sugar in adults with type 2 diabetes and adult and paediatric patients with type 1 diabetes. Semglee contains the same amino acid sequence as Lantus from Sanofi and is licensed for the same indications.
Report Scope
|
Attribute |
Details |
|
Estimated Market Value (2022) |
US$ 3.5 Bn |
|
Projected Market Value (2032) |
US$ 23.9 Bn |
|
Anticipated Growth Rate (2022-2032) |
21.4% |
|
Forecast Period |
2014-2021 |
|
Historical Data Available for |
2022-2032 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, North Africa, and South Africa |
|
Key Market Segments Covered |
Product, Indication, Distribution Channel, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Key Market Segments Covered in Auto-Injectors Industry Research
By Product:
- Prefilled Auto-Injectors
- Fillable Auto-Injectors
By Indication:
- Anaphylaxis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global auto-injectors market size reached US$ 3.1 Bn in 2021 and is set to touch a valuation of US$ 3.5 Bn in 2022.
The auto-injectors market is expected to reach US$ 23.9 Bn by the end of 2032, with overall sales rising at 21.4% CAGR throughout the forecast period.
Growing adoption of advanced products, rising geriatric population, and innovative product development are some of the key trends in shaping the auto-injectors market.
The U.S., Canada, China, Japan, and the U.K. are top countries driving demand for the auto-injectors.
The U.S. accounted for about 91.8% of the North American auto-injectors market in 2021.
Demand for auto-injectors in Japan is expected to grow at a CAGR of 21.3% over the next ten years.
China, Germany, and the U.S. are the key producers of auto-injectors.
Demand for auto-injectors in Latin America is expected to increase at 20.3% CAGR over the next ten years
Demand for auto-injectors in MEA is expected to rise at a CAGR of 14.3% during the forecast period.
Becton, Dickinson and Company, Sanofi, Pfizer, Inc, Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc, Eli Lilly and Company., Teva Pharmaceutical, Merck KgaA, GlaxoSmithKline plc, Ypsomed, and SHL Medical are some of the key players in the auto-injectors industry.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Epidemiology of Key Indication, By Region
4.2. Pipeline Assessment
4.3. Regulatory Scenario
4.4. Reimbursement Landscape
4.5. PESTEL analysis
4.6. Porter’s analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare GDP Growth Overview
5.1.3. Global GDP and Infrastructure Investment
5.1.4. International Trade
5.1.5. Global Syringes and Needles Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Prevalence of Anaphylactic Shocks.
5.2.2. Increasing Awareness and Adoption of for Painless Injection.
5.2.3. New Drug Launches with Auto-Injectors.
5.2.4. Advancing Medical Technology and Developments of Auto-Injectors.
5.3. Value Chain
5.3.1. Raw Material Suppliers
5.3.2. Product Manufacturers
5.3.3. End Users
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Opportunity Analysis
5.5. Global Supply Demand Analysis
6. COVID-19 Crisis – Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Indication
6.1.3. By Distribution Channel
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Volume (Units) Analysis 2014-2021 and Forecast, 2022–2032
7.1. Historical Market Volume (Units) Analysis, 2014-2021
7.2. Current and Future Market Volume (Units) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022–2032
9.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2014-2021 and Forecast 2022–2032, by Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2014-2021
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
10.3.1. Prefilled Auto-Injectors
10.3.2. Fillable Auto-Injectors
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2014-2021 and Forecast 2022–2032, by Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032
11.3.1. Anaphylaxis
11.3.2. Multiple Sclerosis
11.3.3. Rheumatoid Arthritis
11.3.4. Others
11.4. Market Attractiveness Analysis By Indication
12. Global Market Analysis 2014-2021 and Forecast 2022–2032, by Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2014-2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022–2032
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.3.4. Drug Stores
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Market Analysis 2014-2021 and Forecast 2022–2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2014-2021
13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2014-2021 and Forecast 2022–2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021
14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Product
14.4.3. By Indication
14.4.4. By Distribution Channel
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By Indication
14.5.4. By Distribution Channel
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis & Forecast
14.9.1. U.S. Market Analysis
14.9.1.1. .Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Product
14.9.1.2.2. By Indication
14.9.1.2.3. By Distribution Channel
14.9.2. Canada Market Analysis
14.9.2.1. Introduction
14.9.2.2. Market Analysis and Forecast by Market Taxonomy
14.9.2.2.1. By Product
14.9.2.2.2. By Indication
14.9.2.2.3. By Distribution Channel
15. Latin America Market Analysis 2014-2021 and Forecast 2022–2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021
15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032
15.4.1. By Country
15.4.1.1. Mexico
15.4.1.2. Brazil
15.4.1.3. Argentina
15.4.1.4. Rest of Latin America
15.4.2. By Product
15.4.3. By Indication
15.4.4. By Distribution Channel
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By Indication
15.5.4. By Distribution Channel
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast
15.9.1. Mexico Market Analysis
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Product
15.9.1.2.2. By Indication
15.9.1.2.3. By Distribution Channel
15.9.2. Brazil Market Analysis
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Product
15.9.2.2.2. By Indication
15.9.2.2.3. By Distribution Channel
15.9.3. Argentina Market Analysis
15.9.3.1. Introduction
15.9.3.2. Market Analysis and Forecast by Market Taxonomy
15.9.3.2.1. By Product
15.9.3.2.2. By Indication
15.9.3.2.3. By Distribution Channel
16. Europe Market Analysis 2014-2021 and Forecast 2022–2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021
16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. U.K.
16.4.1.5. Spain
16.4.1.6. BENELUX
16.4.1.7. Russia
16.4.1.8. Rest of Europe
16.4.2. By Product
16.4.3. By Indication
16.4.4. By Distribution Channel
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By Indication
16.5.4. By Distribution Channel
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
16.9.1. Germany Market Analysis
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Product
16.9.1.2.2. By Indication
16.9.1.2.3. By Distribution Channel
16.9.2. Italy Market Analysis
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Product
16.9.2.2.2. By Indication
16.9.2.2.3. By Distribution Channel
16.9.3. France Market Analysis
16.9.3.1. Introduction
16.9.3.2. Market Analysis and Forecast by Market Taxonomy
16.9.3.2.1. By Product
16.9.3.2.2. By Indication
16.9.3.2.3. By Distribution Channel
16.9.4. U.K. Market Analysis
16.9.4.1. Introduction
16.9.4.2. Market Analysis and Forecast by Market Taxonomy
16.9.4.2.1. By Product
16.9.4.2.2. By Indication
16.9.4.2.3. By Distribution Channel
16.9.5. Spain Market Analysis
16.9.5.1. Introduction
16.9.5.2. Market Analysis and Forecast by Market Taxonomy
16.9.5.2.1. By Product
16.9.5.2.2. By Indication
16.9.5.2.3. By Distribution Channel
16.9.6. BENELUX Market Analysis
16.9.6.1. Introduction
16.9.6.2. Market Analysis and Forecast by Market Taxonomy
16.9.6.2.1. By Product
16.9.6.2.2. By Indication
16.9.6.2.3. By Distribution Channel
16.9.7. Russia Market Analysis
16.9.7.1. Introduction
16.9.7.2. Market Analysis and Forecast by Market Taxonomy
16.9.7.2.1. By Product
16.9.7.2.2. By Indication
16.9.7.2.3. By Distribution Channel
17. South Asia Market Analysis 2014-2021 and Forecast 2022–2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021
17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Indonesia
17.4.1.3. Malaysia
17.4.1.4. Thailand
17.4.1.5. Rest of South Asia
17.4.2. By Product
17.4.3. By Indication
17.4.4. By Distribution Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By Indication
17.5.4. By Distribution Channel
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast
17.9.1. India Market Analysis
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast by Market Taxonomy
17.9.1.2.1. By Product
17.9.1.2.2. By Indication
17.9.1.2.3. By Distribution Channel
17.9.2. Indonesia Market Analysis
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast by Market Taxonomy
17.9.2.2.1. By Product
17.9.2.2.2. By Indication
17.9.2.2.3. By Distribution Channel
17.9.3. Malaysia Market Analysis
17.9.3.1. Introduction
17.9.3.2. Market Analysis and Forecast by Market Taxonomy
17.9.3.2.1. By Product
17.9.3.2.2. By Indication
17.9.3.2.3. By Distribution Channel
17.9.4. Thailand Market Analysis
17.9.4.1. Introduction
17.9.4.2. Market Analysis and Forecast by Market Taxonomy
17.9.4.2.1. By Product
17.9.4.2.2. By Indication
17.9.4.2.3. By Distribution Channel
18. East Asia Market Analysis 2014-2021 and Forecast 2022–2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021
18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Product
18.4.3. By Indication
18.4.4. By Distribution Channel
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product
18.5.3. By Indication
18.5.4. By Distribution Channel
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
18.9. Country Level Analysis & Forecast
18.9.1. China Market Analysis
18.9.1.1. Introduction
18.9.1.2. Market Analysis and Forecast by Market Taxonomy
18.9.1.2.1. By Product
18.9.1.2.2. By Indication
18.9.1.2.3. By Distribution Channel
18.9.2. Japan Market Analysis
18.9.2.1. Introduction
18.9.2.2. Market Analysis and Forecast by Market Taxonomy
18.9.2.2.1. By Product
18.9.2.2.2. By Indication
18.9.2.2.3. By Distribution Channel
18.9.3. South Korea Market Analysis
18.9.3.1. Introduction
18.9.3.2. Market Analysis and Forecast by Market Taxonomy
18.9.3.2.1. By Product
18.9.3.2.2. By Indication
18.9.3.2.3. By Distribution Channel
19. Oceania Market 2017-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021
19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Product
19.4.3. By Indication
19.4.4. By Distribution Channel
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product
19.5.3. By Indication
19.5.4. By Distribution Channel
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. Australia Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Indication
19.8.1.2.3. By Distribution Channel
19.8.2. New Zealand Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Indication
19.8.2.2.3. By Distribution Channel
20. Middle East and Africa (MEA) Market Analysis 2014-2021 and Forecast 2022–2032
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021
20.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Turkey
20.4.1.3. South Africa
20.4.1.4. North Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Product
20.4.3. By Indication
20.4.4. By Distribution Channel
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product
20.5.3. By Indication
20.5.4. By Distribution Channel
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
20.9. Country Level Analysis & Forecast
20.9.1. GCC Countries Market Analysis
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast by Market Taxonomy
20.9.1.2.1. By Product
20.9.1.2.2. By Indication
20.9.1.2.3. By Distribution Channel
20.9.2. Turkey Market Analysis
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast by Market Taxonomy
20.9.2.2.1. By Product
20.9.2.2.2. By Indication
20.9.2.2.3. By Distribution Channel
20.9.3. South Africa Market Analysis
20.9.3.1. Introduction
20.9.3.2. Market Analysis and Forecast by Market Taxonomy
20.9.3.2.1. By Product
20.9.3.2.2. By Indication
20.9.3.2.3. By Distribution Channel
20.9.4. North Africa Market Analysis
20.9.4.1. Introduction
20.9.4.2. Market Analysis and Forecast by Market Taxonomy
20.9.4.2.1. By Product
20.9.4.2.2. By Indication
20.9.4.2.3. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Becton, Dickinson and Company
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. SWOT Analysis
22.3.1.6. Key Financials
22.3.1.7. Strategy Overview
22.3.2. Sanofi
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. SWOT Analysis
22.3.2.6. Key Financials
22.3.2.7. Strategy Overview
22.3.3. Pfizer, Inc.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. SWOT Analysis
22.3.3.6. Key Financials
22.3.3.7. Strategy Overview
22.3.4. Mylan N.V.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. SWOT Analysis
22.3.4.6. Key Financials
22.3.4.7. Strategy Overview
22.3.5. Novartis AG
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. SWOT Analysis
22.3.5.6. Key Financials
22.3.5.7. Strategy Overview
22.3.6. Bayer AG
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. SWOT Analysis
22.3.6.6. Key Financials
22.3.6.7. Strategy Overview
22.3.7. Janssen Global Services, LLC
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. SWOT Analysis
22.3.7.6. Key Financials
22.3.7.7. Strategy Overview
22.3.8. Antares Pharma, Inc.
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. SWOT Analysis
22.3.8.6. Key Financials
22.3.8.7. Strategy Overview
22.3.9. Amgen Inc.
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. SWOT Analysis
22.3.9.6. Key Financials
22.3.9.7. Strategy Overview
22.3.10. Eli Lilly and Company
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. SWOT Analysis
22.3.10.6. Key Financials
22.3.10.7. Strategy Overview
22.3.11. SHL Medical AG
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. SWOT Analysis
22.3.11.6. Key Financials
22.3.11.7. Strategy Overview
22.3.12. Bespak Europe Ltd
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
22.3.12.4. Sales Footprint
22.3.12.5. SWOT Analysis
22.3.12.6. Key Financials
22.3.12.7. Strategy Overview
22.3.13. Ypsomed AG
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
22.3.13.4. Sales Footprint
22.3.13.5. SWOT Analysis
22.3.13.6. Key Financials
22.3.13.7. Strategy Overview
22.3.14. Teva Pharmaceuticals USA, Inc.
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Profitability by Market Segments (Product/Channel/Region)
22.3.14.4. Sales Footprint
22.3.14.5. SWOT Analysis
22.3.14.6. Key Financials
22.3.14.7. Strategy Overview
22.3.15. Gerresheimer AG
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Profitability by Market Segments (Product/Channel/Region)
22.3.15.4. Sales Footprint
22.3.15.5. SWOT Analysis
22.3.15.6. Key Financials
22.3.15.7. Strategy Overview
22.3.16. Midas Pharma GmbH
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Profitability by Market Segments (Product/Channel/Region)
22.3.16.4. Sales Footprint
22.3.16.5. SWOT Analysis
22.3.16.6. Key Financials
22.3.16.7. Strategy Overview
22.3.17. Aptar Pharma
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Profitability by Market Segments (Product/Channel/Region)
22.3.17.4. Sales Footprint
22.3.17.5. SWOT Analysis
22.3.17.6. Key Financials
22.3.17.7. Strategy Overview
22.3.18. Solteam Medical
22.3.18.1. Overview
22.3.18.2. Product Portfolio
22.3.18.3. Profitability by Market Segments (Product/Channel/Region)
22.3.18.4. Sales Footprint
22.3.18.5. SWOT Analysis
22.3.18.6. Key Financials
22.3.18.7. Strategy Overview
22.3.19. Stevanato Group
22.3.19.1. Overview
22.3.19.2. Product Portfolio
22.3.19.3. Profitability by Market Segments (Product/Channel/Region)
22.3.19.4. Sales Footprint
22.3.19.5. SWOT Analysis
22.3.19.6. Key Financials
22.3.19.7. Strategy Overview
22.3.20. E3D
22.3.20.1. Overview
22.3.20.2. Product Portfolio
22.3.20.3. Profitability by Market Segments (Product/Channel/Region)
22.3.20.4. Sales Footprint
22.3.20.5. SWOT Analysis
22.3.20.6. Key Financials
22.3.20.7. Strategy Overview
22.3.21. West Pharmaceutical Services, Inc.
22.3.21.1. Overview
22.3.21.2. Product Portfolio
22.3.21.3. Profitability by Market Segments (Product/Channel/Region)
22.3.21.4. Sales Footprint
22.3.21.5. SWOT Analysis
22.3.21.6. Key Financials
22.3.21.7. Strategy Overview
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 02: Global Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 03: Global Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication
Table 04: Global Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel
Table 05: Global Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Region
Table 06: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 07: North America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 08: North America Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 09: North America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication
Table 10: North America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel
Table 11: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 12: Latin America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 13: Latin America Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 14: Latin America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication
Table 15: Latin America Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel
Table 16: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 17: Europe Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 18: Europe Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 19: Europe Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication
Table 20: Europe Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel
Table 21: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 22: South Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 23: South Asia Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 24: South Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication
Table 25: South Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel
Table 26: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 27: East Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 28: East Asia Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 29: East Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication
Table 30: East Asia Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel
Table 31: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 32: Oceania Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 33: Oceania Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 34: Oceania Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication
Table 35: Oceania Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel
Table 36: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 37: MEA Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 38: MEA Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 39: MEA Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Indication
Table 40: MEA Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Volume (Units), 2014 – 2021
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032
Figure 03: Auto-Injectors, Pricing Analysis per unit (US$), in 2022
Figure 04: Auto-Injectors, Pricing Forecast per unit (US$), in 2032
Figure 05: Global Market Value (US$ Mn) Analysis, 2014–2021
Figure 06: Global Market Forecast & Y-o-Y Growth, 2022–2032
Figure 07: Global Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032
Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, by Product
Figure 09: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Product
Figure 10: Global Market Attractiveness Analysis 2022–2032, by Product
Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by Indication
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Indication
Figure 13: Global Market Attractiveness Analysis 2022–2032, by Indication
Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Distribution Channel
Figure 16: Global Market Attractiveness Analysis 2022–2032, by Distribution Channel
Figure 17: Global Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 18: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Region
Figure 19: Global Market Attractiveness Analysis 2022–2032, by Region
Figure 20: North America Market Value (US$ Mn) Analysis, 2014–2021
Figure 21: North America Market Value (US$ Mn) Forecast, 2022-2032
Figure 22: North America Market Value Share, by Product (2022 E)
Figure 23: North America Market Value Share, by Indication (2022 E)
Figure 24: North America Market Value Share, by Distribution Channel (2022 E)
Figure 25: North America Market Value Share, by Country (2022 E)
Figure 26: North America Market Attractiveness Analysis by Product, 2022–2032
Figure 27: North America Market Attractiveness Analysis by Indication, 2022–2032
Figure 28: North America Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 29: North America Market Attractiveness Analysis by Country, 2022–2032
Figure 30: U.S. Market Value Proportion Analysis, 2021
Figure 31: Global Vs. U.S. Growth Comparison
Figure 32: U.S. Market Share Analysis (%) by Product, 2021 & 2032
Figure 33: U.S. Market Share Analysis (%) by Indication, 2021 & 2032
Figure 34: U.S. Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 35: Canada Market Value Proportion Analysis, 2021
Figure 36: Global Vs. Canada. Growth Comparison
Figure 37: Canada Market Share Analysis (%) by Product, 2021 & 2032
Figure 38: Canada Market Share Analysis (%) by Indication, 2021 & 2032
Figure 39: Canada Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 40: Latin America Market Value (US$ Mn) Analysis, 2014–2021
Figure 41: Latin America Market Value (US$ Mn) Forecast, 2022-2032
Figure 42: Latin America Market Value Share, by Product (2022 E)
Figure 43: Latin America Market Value Share, by Indication (2022 E)
Figure 44: Latin America Market Value Share, by Distribution Channel (2022 E)
Figure 45: Latin America Market Value Share, by Country (2022 E)
Figure 46: Latin America Market Attractiveness Analysis by Product, 2022–2032
Figure 47: Latin America Market Attractiveness Analysis by Indication, 2022–2032
Figure 48: Latin America Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 49: Latin America Market Attractiveness Analysis by Country, 2022–2032
Figure 50: Mexico Market Value Proportion Analysis, 2021
Figure 51: Global Vs Mexico Growth Comparison
Figure 52: Mexico Market Share Analysis (%) by Product, 2021 & 2032
Figure 53: Mexico Market Share Analysis (%) by Indication, 2021 & 2032
Figure 54: Mexico Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 55: Brazil Market Value Proportion Analysis, 2021
Figure 56: Global Vs. Brazil. Growth Comparison
Figure 57: Brazil Market Share Analysis (%) by Product, 2021 & 2032
Figure 58: Brazil Market Share Analysis (%) by Indication, 2021 & 2032
Figure 59: Brazil Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 60: Argentina Market Value Proportion Analysis, 2021
Figure 61: Global Vs Argentina Growth Comparison
Figure 62: Argentina Market Share Analysis (%) by Product, 2021 & 2032
Figure 63: Argentina Market Share Analysis (%) by Indication, 2021 & 2032
Figure 64: Argentina Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 65: Europe Market Value (US$ Mn) Analysis, 2014–2021
Figure 66: Europe Market Value (US$ Mn) Forecast, 2022-2032
Figure 67: Europe Market Value Share, by Product (2022 E)
Figure 68: Europe Market Value Share, by Indication (2022 E)
Figure 69: Europe Market Value Share, by Distribution Channel (2022 E)
Figure 70: Europe Market Value Share, by Country (2022 E)
Figure 71: Europe Market Attractiveness Analysis by Product, 2022–2032
Figure 72: Europe Market Attractiveness Analysis by Indication, 2022–2032
Figure 73: Europe Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 74: Europe Market Attractiveness Analysis by Country, 2022–2032
Figure 75: UK Market Value Proportion Analysis, 2021
Figure 76: Global Vs. UK Growth Comparison
Figure 77: UK Market Share Analysis (%) by Product, 2021 & 2032
Figure 78: UK Market Share Analysis (%) by Indication, 2021 & 2032
Figure 79: UK Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 80: Germany Market Value Proportion Analysis, 2021
Figure 81: Global Vs. Germany Growth Comparison
Figure 82: Germany Market Share Analysis (%) by Product, 2021 & 2032
Figure 83: Germany Market Share Analysis (%) by Indication, 2021 & 2032
Figure 84: Germany Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 85: Italy Market Value Proportion Analysis, 2021
Figure 86: Global Vs. Italy Growth Comparison
Figure 87: Italy Market Share Analysis (%) by Product, 2021 & 2032
Figure 88: Italy Market Share Analysis (%) by Indication, 2021 & 2032
Figure 89: Italy Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 90: France Market Value Proportion Analysis, 2021
Figure 91: Global Vs France Growth Comparison
Figure 92: France Market Share Analysis (%) by Product, 2021 & 2032
Figure 93: France Market Share Analysis (%) by Indication, 2021 & 2032
Figure 94: France Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 95: Spain Market Value Proportion Analysis, 2021
Figure 96: Global Vs Spain Growth Comparison
Figure 97: Spain Market Share Analysis (%) by Product, 2021 & 2032
Figure 98: Spain Market Share Analysis (%) by Indication, 2021 & 2032
Figure 99: Spain Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 100: Russia Market Value Proportion Analysis, 2021
Figure 101: Global Vs Russia Growth Comparison
Figure 102: Russia Market Share Analysis (%) by Product, 2021 & 2032
Figure 103: Russia Market Share Analysis (%) by Indication, 2021 & 2032
Figure 104: Russia Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 105: BENELUX Market Value Proportion Analysis, 2021
Figure 106: Global Vs BENELUX Growth Comparison
Figure 107: BENELUX Market Share Analysis (%) by Product, 2021 & 2032
Figure 108: BENELUX Market Share Analysis (%) by Indication, 2021 & 2032
Figure 109: BENELUX Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 110: East Asia Market Value (US$ Mn) Analysis, 2014–2021
Figure 111: East Asia Market Value (US$ Mn) Forecast, 2022-2032
Figure 112: East Asia Market Value Share, by Product (2022 E)
Figure 113: East Asia Market Value Share, by Indication (2022 E)
Figure 114: East Asia Market Value Share, by Distribution Channel (2022 E)
Figure 115: East Asia Market Value Share, by Country (2022 E)
Figure 116: East Asia Market Attractiveness Analysis by Product, 2022–2032
Figure 117: East Asia Market Attractiveness Analysis by Indication, 2022–2032
Figure 118: East Asia Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 119: East Asia Market Attractiveness Analysis by Country, 2022–2032
Figure 120: China Market Value Proportion Analysis, 2021
Figure 121: Global Vs. China Growth Comparison
Figure 122: China Market Share Analysis (%) by Product, 2021 & 2032
Figure 123: China Market Share Analysis (%) by Indication, 2021 & 2032
Figure 124: China Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 125: Japan Market Value Proportion Analysis, 2021
Figure 126: Global Vs. Japan Growth Comparison
Figure 127: Japan Market Share Analysis (%) by Product, 2021 & 2032
Figure 128: Japan Market Share Analysis (%) by Indication, 2021 & 2032
Figure 129: Japan Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 130: South Korea Market Value Proportion Analysis, 2021
Figure 131: Global Vs South Korea Growth Comparison
Figure 132: South Korea Market Share Analysis (%) by Product, 2021 & 2032
Figure 133: South Korea Market Share Analysis (%) by Indication, 2021 & 2032
Figure 134: South Korea Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 135: South Asia Market Value (US$ Mn) Analysis, 2014–2021
Figure 136: South Asia Market Value (US$ Mn) Forecast, 2022-2032
Figure 137: South Asia Market Value Share, by Product (2022 E)
Figure 138: South Asia Market Value Share, by Indication (2022 E)
Figure 139: South Asia Market Value Share, by Distribution Channel (2022 E)
Figure 140: South Asia Market Value Share, by Country (2022 E)
Figure 141: South Asia Market Attractiveness Analysis by Product, 2022–2032
Figure 142: South Asia Market Attractiveness Analysis by Indication, 2022–2032
Figure 143: South Asia Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 144: South Asia Market Attractiveness Analysis by Country, 2022–2032
Figure 145: India Market Value Proportion Analysis, 2021
Figure 146: Global Vs. India Growth Comparison
Figure 147: India Market Share Analysis (%) by Product, 2021 & 2032
Figure 148: India Market Share Analysis (%) by Indication, 2021 & 2032
Figure 149: India Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 150: Indonesia Market Value Proportion Analysis, 2021
Figure 151: Global Vs. Indonesia Growth Comparison
Figure 152: Indonesia Market Share Analysis (%) by Product, 2021 & 2032
Figure 153: Indonesia Market Share Analysis (%) by Indication, 2021 & 2032
Figure 154: Indonesia Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 155: Malaysia Market Value Proportion Analysis, 2021
Figure 156: Global Vs. Malaysia Growth Comparison
Figure 157: Malaysia Market Share Analysis (%) by Product, 2021 & 2032
Figure 158: Malaysia Market Share Analysis (%) by Indication, 2021 & 2032
Figure 159: Malaysia Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 160: Thailand Market Value Proportion Analysis, 2021
Figure 161: Global Vs. Thailand Growth Comparison
Figure 162: Thailand Market Share Analysis (%) by Product, 2021 & 2032
Figure 163: Thailand Market Share Analysis (%) by Indication, 2021 & 2032
Figure 164: Thailand Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 165: Oceania Market Value (US$ Mn) Analysis, 2014–2021
Figure 166: Oceania Market Value (US$ Mn) Forecast, 2022-2032
Figure 167: Oceania Market Value Share, by Product (2022 E)
Figure 168: Oceania Market Value Share, by Indication (2022 E)
Figure 169: Oceania Market Value Share, by Distribution Channel (2022 E)
Figure 170: Oceania Market Value Share, by Country (2022 E)
Figure 171: Oceania Market Attractiveness Analysis by Product, 2022–2032
Figure 172: Oceania Market Attractiveness Analysis by Indication, 2022–2032
Figure 173: Oceania Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 174: Oceania Market Attractiveness Analysis by Country, 2022–2032
Figure 175: Australia Market Value Proportion Analysis, 2021
Figure 176: Global Vs. Australia Growth Comparison
Figure 177: Australia Market Share Analysis (%) by Product, 2021 & 2032
Figure 178: Australia Market Share Analysis (%) by Indication, 2021 & 2032
Figure 179: Australia Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 180: New Zealand Market Value Proportion Analysis, 2021
Figure 181: Global Vs New Zealand Growth Comparison
Figure 182: New Zealand Market Share Analysis (%) by Product, 2021 & 2032
Figure 183: New Zealand Market Share Analysis (%) by Indication, 2021 & 2032
Figure 184: New Zealand Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 185: Middle East & Africa Market Value (US$ Mn) Analysis, 2014–2021
Figure 186: Middle East & Africa Market Value (US$ Mn) Forecast, 2022-2032
Figure 187: Middle East & Africa Market Value Share, by Product (2022 E)
Figure 188: Middle East & Africa Market Value Share, by Indication (2022 E)
Figure 189: Middle East & Africa Market Value Share, by Distribution Channel (2022 E)
Figure 190: Middle East & Africa Market Value Share, by Country (2022 E)
Figure 191: Middle East & Africa Market Attractiveness Analysis by Product, 2022–2032
Figure 192: Middle East & Africa Market Attractiveness Analysis by Indication, 2022–2032
Figure 193: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2022–2032
Figure 194: Middle East & Africa Market Attractiveness Analysis by Country, 2022–2032
Figure 195: GCC Countries Market Value Proportion Analysis, 2021
Figure 196: Global Vs GCC Countries Growth Comparison
Figure 197: GCC Countries Market Share Analysis (%) by Product, 2021 & 2032
Figure 198: GCC Countries Market Share Analysis (%) by Indication, 2021 & 2032
Figure 199: GCC Countries Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 200: Turkey Market Value Proportion Analysis, 2021
Figure 201: Global Vs. Turkey Growth Comparison
Figure 202: Turkey Market Share Analysis (%) by Product, 2021 & 2032
Figure 203: Turkey Market Share Analysis (%) by Indication, 2021 & 2032
Figure 204: Turkey Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 205: South Africa Market Value Proportion Analysis, 2021
Figure 206: Global Vs. South Africa Growth Comparison
Figure 207: South Africa Market Share Analysis (%) by Product, 2021 & 2032
Figure 208: South Africa Market Share Analysis (%) by Indication, 2021 & 2032
Figure 209: South Africa Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Figure 210: North Africa Market Value Proportion Analysis, 2021
Figure 211: Global Vs North Africa Growth Comparison
Figure 212: North Africa Market Share Analysis (%) by Product, 2021 & 2032
Figure 213: North Africa Market Share Analysis (%) by Indication, 2021 & 2032
Figure 214: North Africa Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
